There should be a marked increase in revenue for the Q4 reporting with the inclusion of the Reckon dividend and organic growth. Whilst patiently awaiting news of the banking licence, an announcement aligned to a commercial agreement with Reckon would certainly validate the strategic rationale behind taking a sizeable stake in the company. I'm expecting a positive update on this and also the acquisition of ATX before the end of the month or as part of the quarterly update. The general market malaise doesn't change the strong fundamentals or the future growth prospects of the company.
There should be a marked increase in revenue for the Q4...
-
- There are more pages in this discussion • 20 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add NOV (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
7.7¢ |
Change
0.000(0.00%) |
Mkt cap ! $27.39M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 7.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 7.5¢ | 50000 | 1 |
View Market Depth
| Last trade - 09.35am 12/07/2024 (20 minute delay) ? |
| NOV (ASX) Chart |
Day chart unavailable